Mihaela C. Munteanu
Impact in
-
- Lymphoma Diagnosis and Treatment
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Lymphoma Diagnosis and Treatment 12
-
- Chronic Myeloid Leukemia Treatments 5
- Acute Myeloid Leukemia Research 2
- Co-authors
- Ian W. Flinn (6 shared papers)John M. Burke (6 shared papers)Samar Issa (4 shared papers)Mark Hertzberg (4 shared papers)David Simpson (4 shared papers)Kathryn S. Kolibaba (4 shared papers)Brad S. Kahl (5 shared papers)David A. Macdonald (5 shared papers)
- Journals
- Blood (6 papers)BMC Cancer (6 papers)Investigational New Drugs (4 papers)Cancer Chemotherapy and Pharmacology (2 papers)Annals of Hematology (2 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Mihaela C. Munteanu
41 papers receiving 1.2k citations
Mihaela C. Munteanu's Hit Papers
Peers
Comparison fields: 5 of 66
- Pathology and Forensic Medicine 589
- Hematology 173
- Immunology and Allergy 52
- Genetics 68
- Biological Psychiatry 9
Countries citing papers authored by Mihaela C. Munteanu
This map shows the geographic impact of Mihaela C. Munteanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mihaela C. Munteanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mihaela C. Munteanu more than expected).
Fields of papers citing papers by Mihaela C. Munteanu
This network shows the impact of papers produced by Mihaela C. Munteanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mihaela C. Munteanu. The network helps show where Mihaela C. Munteanu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mihaela C. Munteanu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study Hit paper breakdown → | 2014 | 517 |
| 2 | 2002 | 181 | |
| 3 | 2007 | 124 | |
| 4 | 2005 | 94 | |
| 5 | 2015 | 43 | |
| 6 | 2018 | 40 | |
| 7 | 2015 | 29 | |
| 8 | 2012 | 27 | |
| 9 | 2015 | 22 | |
| 10 | 2016 | 18 | |
| 11 | Preliminary report of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine and daunorubicin in patients with acute myeloid leukemia | 2001 | 15 |
| 12 | 2024 | 15 | |
| 13 | 2016 | 14 | |
| 14 | 2024 | 14 | |
| 15 | 2013 | 10 | |
| 16 | 2020 | 10 | |
| 17 | 2024 | 10 | |
| 18 | 2024 | 10 | |
| 19 | 2024 | 9 | |
| 20 | 2024 | 9 |
About Mihaela C. Munteanu
Mihaela C. Munteanu is a scholar working on Pathology and Forensic Medicine, Hematology, Oncology, Nephrology and Pulmonary and Respiratory Medicine, having authored 42 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Cancer Immunotherapy and Biomarkers (8 papers), Chronic Myeloid Leukemia Treatments (5 papers), Lung Cancer Treatments and Mutations (3 papers), Acute Myeloid Leukemia Research (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Pharmaceutical studies and practices (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (589 citations), Hematology (173 citations), Immunology and Allergy (52 citations), Genetics (68 citations) and Biological Psychiatry (9 citations). Mihaela C. Munteanu has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Ian W. Flinn, John M. Burke, Samar Issa, Mark Hertzberg, David Simpson, Kathryn S. Kolibaba, Brad S. Kahl, David A. Macdonald, Patrick Wood and Michael Craig. Their work appears in journals such as Blood, BMC Cancer, Investigational New Drugs, Cancer Chemotherapy and Pharmacology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.